{"database": "openregs", "table": "federal_register", "rows": [["2015-12847", "Bioequivalence Recommendations for Risperidone; Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry on risperidone injection entitled \"Draft Guidance on Risperidone.\" The recommendations provide specific guidance on the design of studies to support abbreviated new drug applications (ANDAs) for risperidone injection. This draft guidance is the second revision of a previously issued draft guidance on the same subject.", "2015-05-27", 2015, 5, "https://www.federalregister.gov/documents/2015/05/27/2015-12847/bioequivalence-recommendations-for-risperidone-draft-guidance-for-industry-availability", "https://www.govinfo.gov/content/pkg/FR-2015-05-27/pdf/2015-12847.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry on risperidone injection entitled \"Draft Guidance on Risperidone.\" The recommendations provide specific guidance on the design of studies to support...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2015-12847"], "units": {}, "query_ms": 81.83200203347951, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}